Quick Answer
CTT PHARMACEUTICAL HOLDINGS, INC. reported Operating Income Loss of $92.2 thousand for the year ending 2013.
- CTT PHARMACEUTICAL HOLDINGS, INC. showed an increase of +107.7% in Operating Income Loss from 2012 to 2013.
- This data is from CTT PHARMACEUTICAL HOLDINGS, INC.'s annual report (Form 10-K), filed with the SEC on February 10, 2014.
- XBRL data for this metric is available from 2010 to 2013 (4 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q2 2010: -$385.6 thousand | Q3 2010: -$981.6 thousand | Q1 2011: -$26.9 thousand | Q2 2011: -$436.8 thousand | Q3 2011: -$107.4 thousand | Q1 2012: -$582.8 thousand | Q2 2012: -$191.5 thousand | Q3 2012: -$118.5 thousand | Q1 2013: -$60.3 thousand | Q2 2013: -$62.5 thousand | Q3 2013: -$25.7 thousand | Q1 2014: -$27.2 thousand | Q2 2014: -$22.3 thousand.
- Over the full 4 years of available data (2010 to 2013), CTT PHARMACEUTICAL HOLDINGS, INC.'s Operating Income Loss has grown by 104.5%.
- Historical annual values: Fiscal year 2013: $92.2 thousand | Fiscal year 2012: -$1.19 million | Fiscal year 2011: -$757.9 thousand | Fiscal year 2010: -$2.07 million.
- Data sourced from SEC EDGAR public filings as of August 7, 2026.
Last verified: